Zacks Investment Research on MSN
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using ‘longevity genes’ ...
An experimental gene therapy has successfully treated dozens of children with a rare and fatal immune disorder, a promising ...
An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has ...
Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the ...
New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...
Stevie Ringel is the founder of the Kizuna Foundation, an organization seeking a treatment for a genetic retinal mutation ...
An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has ...
With a new COO and several consultants that were formerly as Spark Therapeutics, CorriXR plans on "rewriting the rules of ...
In a study published in Nature Medicine, Leone and her team reported the first targeted gene therapy to restore myelin, the ...
Despite announcing a broad pivot to siRNA earlier this year, Sarepta is following through with an investigational gene ...
A novel, validated seven-gene transcriptomic signature can predict TNF inhibitor response in patients with rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback